Choose language
Do you want to set the chosen language as default?
Yes, set as default
Search
Trending Topics
Stock

Amazon

 Stock

Apple

 Stock

Alphabet

 Stock

SpaceX

 Commodities

Oil prices

 Asset

ETFs

Stocks

See all

ETFs

See all

Cryptocurrencies

See all

Tools

PRTK

Paratek Pharmaceuticals Inc.

This asset is no longer available for investment.
View all assets

Price

$-

return (12m)

0.00% Logo

p/e

-2.04

p/bv

-0.63

DIVIDEND YIELD

0.00%
graph

PRTK price

Select period
Select period
Paratek Pharmaceuticals
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment PRTK

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
0.00%
3 months
0.00%
1 year
0.00%
2 years
0.00%
5 years
0.00%
10 years
0.00%
Fundamental indicators

Fundamentals PRTK

Check the fundamentals of Paratek Pharmaceuticals shares.

Valuation

P/E
-2.04
Sector -3.98
Industry -3.98
P/BV
-0.63
Sector 2.00
Industry 2.00
P/Revenue (PSR)
0.63
Sector -4.41
Industry -4.41
EV/EBITDA
-19.46
Sector -245.01
Industry -245.01
EV/EBIT
-19.37
Sector -666.51
Industry -666.51
P/EBITDA
-1.82
Sector -4.07
Industry -4.07
P/EBIT
-1.80
Sector -4.24
Industry -4.24
P/Total Assets
0.88
Sector 1.40
Industry 1.40
P/Net Current Assets
-
Sector -11.65
Industry -11.65
P/Working Capital
-
Sector -10.95
Industry -10.95
EPS
-1.10
Sector -2.20
Industry -2.20
BVPS
-3.52
Sector 1.95
Industry 1.95

Efficiency

Gross Margin
83.47%
Sector 36.05%
Industry 36.05%
EBITDA Margin
-24.21%
Sector -16,817.20%
Industry -16,817.20%
EBIT Margin
-24.33%
Sector -4,256,841.62%
Industry -4,256,841.62%
Operating Margin
-35.06%
Sector -38.74%
Industry -38.74%
Net Profit Margins
-30.79%
Sector -39.50%
Industry -39.50%
Asset Turnover
0.26
Sector 0.03
Industry 0.03

Profitability

ROE
31.15%
Sector -66.41%
Industry -66.41%
ROA
-43.03%
Sector -66.55%
Industry -66.55%
ROIC
-
Sector -1,703.97%
Industry -1,703.97%

Dividends

Dividend yield
0.00%
Sector -
Industry -
Payout
-
Sector -
Industry -

Debt

Current Ratio
-
Sector 2.90
Industry 2.90
Net Debt / EBITDA
-5.60
Sector -14.63
Industry -14.63
Net Debt / EBIT
-5.57
Sector -7.24
Industry -7.24
Net Debt / Equity
-0.26
Sector -33,201.65
Industry -33,201.65
Gross Debt / Equity
-0.47
Sector -0.02
Industry -0.02
Equity/Assets
-1.38
Sector 0.42
Industry 0.42
Liabilities/Assets
-1.38
Sector 0.39
Industry 0.39

Growth

5Y Revenue CAGR
10.24%
Sector -
Industry -
5Y Earnings CAGR
1.21%
Sector -
Industry -
Histórico de indicadores fundamentalistas

Fundamentals PRTK

Buy And Hold Investor Checklist

Paratek Pharmaceuticals Buy And Hold Investor Checklist


This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]

Stock Comparison Tool

graph

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Price

PRTK Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

ABOUT

Logo Paratek Pharmaceuticals

Paratek Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

United States

25 years

Founded: 2001

2006

Time since IPO - 20 years

197

Employees

Market cap

$127.74 million

$127.74 million

Net worth

$-201.37 million

$-201,365,000.00

Assets

$145.79 million

$145,792,000.00

Total Shares Outstanding

57.28 million

57,282,000

Average Daily Trading Volume

$574.81 Thousand

$574,813.78

Sector

Health Care

Industry

Biotechnology

Shares

PRTK
receitas e lucros

PRTK revenue and profits

graph

PROFIT X PRICE PRTK

Financials

Financial Results PRTK

DRAG THE FRAME TO SEE MORE DATA
Financials

PRTK cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - PRTK

Pontos Relevantes

PRTK balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more assets
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12M)
P/E

0.00

DY

0.00%

ROE

-893.55%

P/BV

0.00
Logo McKesson

MCK - McKesson

$827.14 16,95% (12M)
P/E

22.00

DY

0.38%

ROE

-570.98%

P/BV

-125.59
Logo Cardinal Health

CAH - Cardinal Health

$235.60 50,09% (12M)
P/E

34.61

DY

0.89%

ROE

-58.20%

P/BV

-20.14
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$254.41 53,26% (12M)
P/E

29.40

DY

2.04%

ROE

24.76%

P/BV

7.28
Logo AbbVie

ABBV - AbbVie

$245.10 29,37% (12M)
P/E

71.07

DY

2.66%

ROE

-%

P/BV

0.00
Logo Merck & Co.

MRK - Merck & Co.

$127.77 66,38% (12M)
P/E

35.97

DY

2.58%

ROE

19.45%

P/BV

7.00
Logo AstraZeneca

AZN - AstraZeneca

$157.97 8,58% (12M)
P/E

25.16

DY

1.89%

ROE

20.74%

P/BV

5.22
Logo Novo Nordisk

NVO - Novo Nordisk

$47.09 4,55% (12M)
P/E

11.00

DY

3.96%

ROE

60.40%

P/BV

6.65
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12 M)
P/L

0.00

DY

0.00%

ROE

-893.55%

P/VP

0.00
Logo McKesson

MCK - McKesson

$827.14 16,95% (12 M)
P/L

22.00

DY

0.38%

ROE

-570.98%

P/VP

-125.59
Logo Cardinal Health

CAH - Cardinal Health

$235.60 50,09% (12 M)
P/L

34.61

DY

0.89%

ROE

-58.20%

P/VP

-20.14
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$254.41 53,26% (12 M)
P/L

29.40

DY

2.04%

ROE

24.76%

P/VP

7.28
Logo AbbVie

ABBV - AbbVie

$245.10 29,37% (12 M)
P/L

71.07

DY

2.66%

ROE

-%

P/VP

0.00
Logo Merck & Co.

MRK - Merck & Co.

$127.77 66,38% (12 M)
P/L

35.97

DY

2.58%

ROE

19.45%

P/VP

7.00
Logo AstraZeneca

AZN - AstraZeneca

$157.97 8,58% (12 M)
P/L

25.16

DY

1.89%

ROE

20.74%

P/VP

5.22
Logo Novo Nordisk

NVO - Novo Nordisk

$47.09 4,55% (12 M)
P/L

11.00

DY

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Paratek Pharmaceuticals (PRTK) today?

A cotação de Paratek Pharmaceuticals (PRTK) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Paratek Pharmaceuticals (PRTK) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Paratek Pharmaceuticals (PRTK) e dados de ações do Ibovespa e mercados internacionais.

Quando Paratek Pharmaceuticals (PRTK) paga dividendos?

Paratek Pharmaceuticals (PRTK) não distribuiu dividendos no último ano.

Is Paratek Pharmaceuticals (PRTK) a good investment?

Atualmente, Paratek Pharmaceuticals (PRTK) está cotada a US$ 0.00, com um P/L de -2.04, representando um desvio de -182% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Paratek Pharmaceuticals (PRTK) stock?

Investir em ações de Paratek Pharmaceuticals (PRTK) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Paratek Pharmaceuticals (PRTK) yield today?

A rentabilidade de Paratek Pharmaceuticals (PRTK) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Paratek Pharmaceuticals (PRTK) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

  • Em 1 ano: US$ 0.00
  • Em 5 anos: US$ 0.00
  • Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.